Filtros de búsqueda

Lista de obras de Oskar Hansson

18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease

artículo científico publicado en 2017

18F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies.

artículo científico publicado en 2018

18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers

artículo científico publicado en 2016

1st Conference Clinical Trials on Alzheimer’s Disease September 17-18-19, 2008 School of Medecine Montpellier, France

article

A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease

artículo científico publicado en 2016

A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease

artículo científico publicado en 2010

A fast analysis system for forensic DNA reference samples.

artículo científico publicado en 2008

A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies

scientific article published on 21 June 2019

A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease

artículo científico publicado en 2017

A porous silicon immunoassay platform for fluorometric determination of α-synuclein in human cerebrospinal fluid

A quick test of cognitive speed can predict development of dementia in Parkinson's disease

scientific article published on 28 October 2019

A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls.

artículo científico publicado en 2013

Abnormal Structural Brain Connectome in Individuals with Preclinical Alzheimer's Disease.

artículo científico publicado en 2017

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders

artículo científico publicado en 2012

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography

artículo científico publicado en 2014

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms

scholarly article by Sebastian Palmqvist et al published 23 October 2018 in Alzheimer's and Dementia

Additive Effects of Caspase Inhibitor and Lazaroid on the Survival of Transplanted Rat and Human Embryonic Dopamine Neurons

artículo científico publicado en 2000

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease

artículo científico publicado en 2019

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

artículo científico publicado en 2012

Alteration of putaminal fractional anisotropy in Parkinson's disease: a longitudinal diffusion kurtosis imaging study

artículo científico publicado en 2018

Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease

artículo científico publicado en 2016

Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease

artículo científico publicado en 2010

Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters

artículo científico publicado en 2012

Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice

artículo científico publicado en 2001

Altered structural network organization in cognitively normal individuals with amyloid pathology.

artículo científico publicado en 2017

Alzheimer Disease: Standard of Diagnosis, Treatment, Care, and Prevention

artículo científico publicado en 2022

Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

artículo científico publicado en 2015

Amyloid Network Topology Characterizes the Progression of Alzheimer's Disease During the Predementia Stages.

artículo científico publicado en 2017

Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity

artículo científico publicado en 2019

Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods

artículo científico publicado en 2007

Amyloid biomarkers in Alzheimer's disease

artículo científico publicado en 2015

Amyloid blood biomarker detects Alzheimer's disease.

artículo científico publicado en 2018

Amyloid pathology in the progression to mild cognitive impairment

artículo científico publicado en 2017

Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

scientific article published on 01 November 2020

Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease

artículo científico publicado en 2012

An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease

artículo científico publicado en 2014

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease

artículo científico publicado en 2015

Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment

artículo científico publicado en 2011

Apathy and anxiety are early markers of Alzheimer's disease

artículo científico publicado en 2019

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease

artículo científico publicado en 2014

Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information

artículo científico publicado en 2016

Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease

artículo científico publicado en 2020

Assessment of global and regional diffusion changes along white matter tracts in parkinsonian disorders by MR tractography.

artículo científico publicado en 2013

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease

artículo científico publicado en 2018

Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms

artículo científico publicado en 2014

Association Between Earliest Amyloid Uptake and Functional Connectivity in Cognitively Unimpaired Elderly

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

artículo científico publicado en 2006

Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease

artículo científico publicado en 2017

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

artículo científico publicado en 2017

Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein

Association of enlarged perivascular spaces and measures of small vessel and Alzheimers disease

artículo científico publicado en 2020

Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism

artículo científico publicado en 2016

Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease

Atrophy of the Posterior Subiculum Is Associated with Memory Impairment, Tau- and Aβ Pathology in Non-demented Individuals

artículo científico publicado en 2017

Autocatalytic amplification of Alzheimer-associated Aβ42 peptide aggregation in human cerebrospinal fluid

scientific article published on 08 October 2019

Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease

scientific article published on 15 April 2020

Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseases

artículo científico publicado en 2012

Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease

artículo científico publicado en 2010

Beta-blocker therapy and risk of vascular dementia: A population-based prospective study

scientific article published on 17 January 2020

Biomarker testing in MCI patients-deciding who to test

artículo científico publicado en 2021

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

scientific article published on 13 September 2019

Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study.

artículo científico publicado en 2017

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

artículo científico publicado en 2020

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder

artículo científico publicado en 2017

Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

artículo científico publicado en 2011

Brain activity and Alzheimer's disease: a complex relationship

artículo científico publicado en 2016

Brain charts for the human lifespan

artículo científico publicado en 2022

Brain myoinositol as a potential marker of amyloid-related pathology

scholarly article by Olga Voevodskaya et al published 4 January 2019 in Neurology

CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease

artículo científico publicado en 2012

CDH6 and HAGH protein levels in plasma associate with Alzheimer's disease in APOE ε4 carriers

scientific article published on 19 May 2020

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

artículo científico publicado en 2016

CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.

artículo científico publicado en 2008

CSF and blood biomarkers for Parkinson's disease

scientific article published on 10 April 2019

CSF biomarkers and clinical progression of Parkinson disease

artículo científico publicado en 2014

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

artículo científico publicado en 2009

CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly

artículo científico publicado en 2012

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4.

artículo científico publicado en 2013

CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

artículo científico publicado en 2018

CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease

CSF biomarkers predict a more malignant outcome in Alzheimer disease.

artículo científico publicado en 2010

CSF placental growth factor - a novel candidate biomarker of frontotemporal dementia

CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients

artículo científico

Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?

artículo científico publicado en 2009

Caspase inhibition reduces apoptosis and increases survival of nigral transplants

artículo científico publicado en 1999

Cerebral Microbleeds and White Matter Hyperintensities in Cognitively Healthy Elderly: A Cross-Sectional Cohort Study Evaluating the Effect of Arterial Stiffness

artículo científico publicado en 2015

Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people.

artículo científico publicado en 2017

Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET

artículo científico publicado en 2016

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease

scientific article published on 09 January 2020

Cerebrospinal Fluid Concentrations of Extracellular Matrix Proteins in Alzheimer's Disease

scientific article published on 01 January 2019

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates

artículo científico

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease

artículo científico publicado en 2013

Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography

artículo científico publicado en 2016

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

scientific article published on 11 November 2019

Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population

artículo científico publicado en 2011

Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis.

artículo científico publicado en 2017

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.

artículo científico publicado en 2007

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders

artículo científico publicado en 2018

Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment.

artículo científico publicado en 2013

Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients

artículo científico publicado en 2015

Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease

article

Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia

artículo científico publicado en 2013

Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders

scientific article published on 13 December 2019

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

artículo científico publicado en 2014

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

artículo científico publicado en 2012

Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia

artículo científico publicado en 2020

Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility.

artículo científico publicado en 2011

Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease

artículo científico publicado en 2015

Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration

scientific article published on 25 October 2019

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease

scientific article published on 03 April 2020

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease

artículo científico publicado en 2016

Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology

artículo científico publicado en 2020

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

scientific article published on 17 August 2016

Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.

artículo científico publicado en 2010

Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.

artículo científico publicado en 2009

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer's disease: an observational study

artículo científico publicado en 2014

Characterisation of artefacts and drop-in events using STR-validator and single-cell analysis.

artículo científico publicado en 2017

Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process.

artículo científico publicado en 2016

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls

artículo científico publicado en 2015

Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient?

artículo científico publicado en 2016

Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

artículo científico publicado en 2017

Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia

artículo científico publicado en 2019

Cognitive and functional changes associated with Aβ pathology and the progression to mild cognitive impairment

artículo científico publicado en 2016

Cognitively normal women with Alzheimer's disease proteinopathy show relative preservation of memory but not of hippocampal volume

artículo científico publicado en 2019

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease

artículo científico publicado en 2007

Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease

artículo científico publicado en 2018

Comparing progression biomarkers in clinical trials of early Alzheimer's disease

scientific article published on 11 August 2020

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study

artículo científico publicado en 2012

Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment

artículo científico publicado en 2017

Converging pathways of chromogranin and amyloid metabolism in the brain

artículo científico publicado en 2010

Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology

scientific article published on 01 March 2019

Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.

artículo científico publicado en 2010

Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies

artículo científico publicado en 2012

Corrigendum to: "Striatal changes in Parkinson disease: An investigation of morphology, functional connectivity and their relationship to clinical symptoms" [Psychiatry Research: Neuroimaging. Volume 275 (May 2018), Pages 5-13]

artículo científico publicado en 2019

Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progression

Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease

artículo científico publicado en 2008

Cyclosporin A and Bcl-2 do not inhibit quinolinic acid-induced striatal excitotoxicity in rodents

artículo científico publicado en 2003

Cystatin C Levels are Positively Correlated with both Aβ42 and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls

scholarly article by Johan Sundelöf et al published 11 August 2010 in Journal of Alzheimer's Disease

Data-driven approaches for Tau-PET imaging biomarkers in Alzheimer's disease

scholarly article published 11 January 2018

Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease

scholarly article by Jacob W Vogel et al published 19 October 2018 in Human Brain Mapping

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

artículo científico publicado en 2015

Determining clinically meaningful decline in preclinical Alzheimer disease

scientific article published on 09 July 2019

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

artículo científico publicado en 2010

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

artículo científico publicado en 2019

Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health

artículo científico publicado en 2013

Dietary intervention with an Okinawan-based Nordic diet in type 2 diabetes renders decreased interleukin-18 concentrations and increased neurofilament light concentrations in plasma

scientific article published on 19 August 2018

Differences in survival between patients with dementia with Lewy bodies and patients with Alzheimer's disease--measured from a fixed cognitive level

artículo científico publicado en 2011

Diffusion Tensor MRI to Distinguish Progressive Supranuclear Palsy from α-Synucleinopathies

scientific article published on 15 October 2019

Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders

artículo científico publicado en 2018

Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases

artículo científico publicado en 2011

Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy

artículo científico publicado en 2015

Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease

artículo científico publicado en 2017

Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease

artículo científico publicado en 2010

Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease

artículo científico publicado en 2020

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

artículo científico publicado en 2017

Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease

scientific article published on 11 July 2018

Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment

artículo científico publicado en 2011

Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid

artículo científico publicado en 2019

Electroencephalogram variability in dementia with lewy bodies, Alzheimer's disease and controls.

artículo científico publicado en 2008

Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease

artículo científico publicado en 2008

Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.

artículo científico publicado en 2008

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease

scientific article published on 14 September 2019

European Ultrahigh-Field Imaging Network for Neurodegenerative Diseases (EUFIND)

artículo científico publicado en 2019

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

artículo científico publicado en 2013

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

scholarly article by Joakim Hertze et al published 10 September 2010 in Journal of Alzheimer's Disease

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years

artículo científico publicado en 2010

Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease

artículo científico publicado en 2012

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

artículo científico publicado en 2008

Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study

artículo científico publicado en 2012

Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

scholarly article by Oskar Hansson et al published April 2010 in Neurobiology of Aging

Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders

artículo científico publicado en 2013

Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment

artículo científico publicado en 2009

Extensive changes in the transcriptional profile of human adipose tissue including genes involved in oxidative phosphorylation after a 6-month exercise intervention

article

External validation of a 3-step falls prediction model in mild Parkinson's disease.

artículo científico publicado en 2016

Extrapolation-Based References Improve Motion and Eddy-Current Correction of High B-Value DWI Data: Application in Parkinson's Disease Dementia

artículo científico publicado en 2015

Extreme sleep pattern in Lewy body dementia: a hypothalamic matter?

artículo científico publicado en 2019

F-Flortaucipir in TDP-43 associated frontotemporal dementia

artículo científico publicado en 2019

FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons.

artículo científico publicado en 2000

Factors associated with fear of falling in people with Parkinson's disease

artículo científico publicado en 2014

Flt3 ligand does not differentiate between Parkinsonian disorders

artículo científico publicado en 2014

Fluid biomarkers in Alzheimer's disease - current concepts

artículo científico publicado en 2013

Flunarizine improves the survival of grafted dopaminergic neurons

scholarly article by G.S Kaminski Schierle et al published September 1999 in Neuroscience

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease

scientific article published on 17 January 2020

Genetic characterization of amyloid-β and tau network spread

artículo científico publicado en 2018

Genotyping and interpretation of STR-DNA: Low-template, mixtures and database matches-Twenty years of research and development.

artículo científico

Graft survival

artículo científico publicado en 1999

Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study

scholarly article by Niklas Mattsson et al published 7 August 2018 in Alzheimers Research & Therapy

Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948

scientific article published on 14 October 2019

Hepatocyte growth factor in cerebrospinal fluid differentiates community-acquired or nosocomial septic meningitis from other causes of pleocytosis

artículo científico publicado en 2015

Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism

artículo científico publicado en 2016

High circulating levels of midregional proenkephalin A predict vascular dementia: a population-based prospective study

artículo científico publicado en 2020

Higher Cathepsin B Levels in Plasma in Alzheimer's Disease Compared to Healthy Controls

scholarly article by Johan Sundelöf et al published 7 January 2011 in Journal of Alzheimer's Disease

Huntington disease--yet another mad protein?

artículo científico publicado en 2001

Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid

artículo científico publicado en 2012

Improving the survival of grafted dopaminergic neurons: a review over current approaches.

artículo científico publicado en 2000

Improving the survival of grafted embryonic dopamine neurons in rodent models of Parkinson's disease

artículo científico publicado en 2000

In vivo retention of 18F-AV-1451 in corticobasal syndrome.

artículo científico publicado en 2017

Increased CSF biomarkers of angiogenesis in Parkinson disease

artículo científico publicado en 2015

Increased CSF biomarkers of angiogenesis in Parkinson disease.

artículo científico publicado en 2016

Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis

artículo científico publicado en 2016

Increased basal ganglia binding of 18 F-AV-1451 in patients with progressive supranuclear palsy

artículo científico publicado en 2016

Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype

artículo científico publicado en 2016

Increased functional connectivity of thalamic subdivisions in patients with Parkinson's disease

artículo científico publicado en 2019

Increased levels of hyaluronic acid in cerebrospinal fluid in patients with vascular dementia

artículo científico publicado en 2014

Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later

artículo científico publicado en 2017

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease

artículo científico publicado en 2002

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

scientific article published on 07 December 2020

Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

artículo científico publicado en 2009

Is longitudinal tau PET ready for use in Alzheimer's disease clinical trials?

artículo científico publicado en 2018

Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease

artículo científico publicado en 2007

Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies

artículo científico publicado en 2020

Lack of neuroprotection by heat shock protein 70 overexpression in a mouse model of global cerebral ischemia.

artículo científico publicado en 2003

Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study

artículo científico publicado en 2011

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease

artículo científico publicado en 2014

Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer's disease

scientific article published on 17 June 2019

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease

artículo científico publicado en 2016

Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study

artículo científico publicado en 2015

Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease

scientific article published on 05 March 2020

Longitudinal study of CSF biomarkers in patients with Alzheimer's disease

artículo científico publicado en 2009

Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy

artículo científico publicado en 2013

Low IL-8 is associated with anxiety in suicidal patients: genetic variation and decreased protein levels.

artículo científico publicado en 2014

Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients

artículo científico publicado en 2010

Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies

artículo científico publicado en 2014

Low prevalence of known pathogenic mutations in dominant PD genes: A Swedish multicenter study

scientific article published on 31 July 2019

MRI of the Swallow Tail Sign: A Useful Marker in the Diagnosis of Lewy Body Dementia?

artículo científico publicado en 2017

Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism

artículo científico publicado en 2019

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders

artículo científico publicado en 2017

Method comparison study of the Elecsys® β-Amyloid (1-42) CSF assay versus comparator assays and LC-MS/MS

artículo científico publicado en 2019

Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine

artículo científico publicado en 2001

Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia.

artículo científico publicado en 2013

Midlife Atherosclerosis and Development of Alzheimer or Vascular Dementia

artículo científico publicado en 2019

Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer's disease

artículo científico publicado en 2019

Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women

scholarly article by Per Johansson et al published 5 August 2011 in Clinical Endocrinology

Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology

artículo científico publicado en 2016

Molecular properties underlying regional vulnerability to Alzheimer's disease pathology

artículo científico publicado en 2018

Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment

artículo científico publicado en 2012

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease

scientific article published on 06 November 2019

Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease

artículo científico publicado en 2016

N-Terminal Prosomatostatin and Risk of Vascular Dementia.

artículo científico publicado en 2017

NG2 cells, a new trail for Alzheimer's disease mechanisms?

artículo científico publicado en 2013

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.

artículo científico publicado en 2010

Neuronal death in nigral grafts in the absence of poly (ADP-ribose) polymerase activation

artículo científico publicado en 1999

No diagnostic value of plasma clusterin in Alzheimer's disease

artículo científico publicado en 2012

No independent association between pulse wave velocity and dementia: a population-based, prospective study

artículo científico publicado en 2017

Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum

artículo científico publicado en 2012

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment

artículo científico publicado en 2007

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.

artículo científico publicado en 2018

OUP accepted manuscript

article by Valentina Gallo et al published 2018 in International Journal of Epidemiology

Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes

artículo científico publicado en 2016

Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression

artículo científico publicado en 2003

Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons.

artículo científico publicado en 2000

Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD Study

artículo científico publicado en 2015

Parkinson's disease: evolution of cognitive impairment and CSF Aβ1-42 profiles in a prospective longitudinal study

artículo científico publicado en 2018

Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length

artículo científico publicado en 2001

Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer's disease

artículo científico publicado en 2020

Patterns of Cell Death and Dopaminergic Neuron Survival in Intrastriatal Nigral Grafts

scholarly article by Mia Emgård et al published November 1999 in Experimental Neurology

Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status

scientific article published on 24 June 2019

Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals

artículo científico publicado en 2022

Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease

scientific article published on 23 August 2020

Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia

artículo científico publicado en 2020

Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study

artículo científico publicado en 2014

Plasma phosphorylated tau181 and neurodegeneration in Alzheimer's disease

scientific article published on 29 November 2020

Plasma tau in Alzheimer disease

scientific article published on 30 September 2016

Plasma tau levels in Alzheimer's disease

artículo científico publicado en 2013

Plasma β-amyloid in Alzheimer's disease and vascular disease

artículo científico publicado en 2016

Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.

artículo científico publicado en 2016

Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests

artículo científico publicado en 2009

Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium

artículo científico publicado en 2016

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations

artículo científico publicado en 2017

Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort

artículo científico publicado en 2013

Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Aβ(1-42), pTau and tTau CSF immunoassays

scientific article published on 13 December 2019

Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease

artículo científico publicado en 2019

Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting

artículo científico publicado en 2008

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides

artículo científico publicado en 2008

Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment

artículo científico publicado en 2010

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

artículo científico publicado en 2007

Prediction of falls and/or near falls in people with mild Parkinson's disease

artículo científico publicado en 2015

Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia

artículo científico publicado en 2018

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

artículo científico publicado en 2018

Primary fatty amides are potential plasma biomarkers for AD

scientific article published on 01 September 2019

Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy

artículo científico publicado en 2013

Psychometric testing of a Swedish version of the Apathy Evaluation Scale.

artículo científico publicado en 2017

Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

artículo científico publicado en 2021

Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases

artículo científico publicado en 2020

Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer’s disease and other neurodegenerative diseases

Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)

artículo científico publicado en 2017

Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease

artículo científico publicado en 2012

Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.

artículo científico publicado en 2016

Regional times to equilibria and their impact on semi-quantification of [18F]AV-1451 uptake

scientific article published on 03 August 2018

Reply: Do we still need positron emission tomography for early Alzheimer's disease diagnosis?

artículo científico publicado en 2016

Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder

artículo científico publicado en 2017

Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene

artículo científico publicado en 2001

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease

artículo científico publicado en 2014

STR-validator: an open source platform for validation and process control.

artículo científico publicado en 2014

Searching for the neurite density with diffusion MRI: Challenges for biophysical modeling

scientific article published on 25 February 2019

Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease

articulo cientifico

Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years

article

Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review.

artículo científico publicado en 2018

Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment

artículo científico publicado en 2010

Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease

artículo científico publicado en 2013

Spatial navigation measured by the Floor Maze Test in patients with subjective cognitive impairment, mild cognitive impairment, and mild Alzheimer's disease

artículo científico publicado en 2015

Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

scientific article published on 26 May 2020

Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography

scientific article published on 17 July 2019

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

artículo científico publicado en 2017

Striatal changes in Parkinson disease: An investigation of morphology, functional connectivity and their relationship to clinical symptoms.

artículo científico publicado en 2018

Structural imaging findings on non-enhanced computed tomography are severely underreported in the primary care diagnostic work-up of subjective cognitive decline

scholarly article by Claes Håkansson et al published April 2019 in Neuroradiology

Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease

artículo científico publicado en 2017

Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks

scientific article published on 31 March 2017

Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy

artículo científico publicado en 2016

Tau oligomers in cerebrospinal fluid in Alzheimer's disease

artículo científico publicado en 2017

Tau pathology and parietal white matter lesions have independent but synergistic effects on early development of Alzheimer's disease

artículo científico publicado en 2013

The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adults

artículo científico publicado en 2020

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies

artículo científico publicado en 2015

The Swedish SCOPA-SLEEP for assessment of sleep disorders in Parkinson's disease and healthy controls.

artículo científico publicado en 2016

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

artículo científico publicado en 2014

The clinical significance of 10-m walk test standardizations in Parkinson's disease

artículo científico publicado en 2018

The effect of white matter hyperintensities on statistical analysis of diffusion tensor imaging in cognitively healthy elderly and prodromal Alzheimer's disease.

artículo científico publicado en 2017

The impact of demographic, clinical, genetic, and imaging variables on tau PET status

scientific article published on 19 November 2020

The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review

scientific article published on 23 June 2018

The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individuals

artículo científico publicado en 2017

The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies

scientific article published on 01 February 2008

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease

artículo científico publicado en 2016

The usefulness of cube copying for evaluating treatment of Alzheimer's disease.

artículo científico publicado en 2008

Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease

artículo científico publicado en 2017

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls

artículo científico publicado en 2014

Towards a unified protocol for handling of CSF before β-amyloid measurements

scientific article published on 19 July 2019

Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity

artículo científico publicado en 1999

[18F]Flortaucipir distinguishes Alzheimer's disease from progressive supranuclear palsy pathology in a mixed-pathology case

artículo científico publicado en 2020

α-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients

scientific article published on 03 July 2019

β-Amyloid peptides and amyloid plaques in Alzheimer's disease

artículo científico publicado en 2015

β-amyloid pathology and hippocampal atrophy are independently associated with memory function in cognitively healthy elderly

artículo científico publicado en 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda